Dr. Mustafa Serkan Alemdar berspesialisasi dalam onkologi medis dengan fokus kuat pada pengobatan kanker ginjal di Kompleks Rumah Sakit Medical Park Antalya.
Prof. Madya Nail Paksoy berspesialisasi dalam kemoterapi kanker ginjal di Rumah Sakit Medipol Bahçelievler, dengan fokus pada kasus refraktori dan terapi baru.
Prof. Madya Atakan Topcu berspesialisasi dalam terapi target dan imunoterapi untuk kanker ginjal di Rumah Sakit Distrik Medipol Acibadem.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.
Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).
Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).
Profesor Madya Onkologi Medis di Rumah Sakit Liv Topkapı Universitas İstinye – berspesialisasi dalam kemoterapi kanker ginjal dengan publikasi penelitian yang ekstensif.
Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.
He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.
His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.
He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.
Dr. Shruti Kate berspesialisasi dalam kemoterapi tingkat lanjut untuk kanker ginjal, dengan keahlian dalam imunoterapi dan terapi metronomik di HCG Manavata Cancer Centre.
Dr. Raj Nagarkar telah melakukan lebih dari 50.000 operasi kanker dengan 19 tahun pengalaman, spesialisasi dalam Onkologi Bedah Payudara dan Toraks.
Dr. Shaunak Valame berspesialisasi dalam perawatan kanker berbasis molekuler dan telah mempresentasikan penelitian di American Society of Clinical Oncology.
10.000+ operasi besar yang berhasil – Dr. Lalit berfokus pada teknik invasif minimal untuk bedah kanker dengan hasil yang sangat baik.
Dr. Ahmer Arif Shaikh berspesialisasi dalam onkologi bedah dengan fokus pada kanker mulut, pelestarian organ, dan rehabilitasi fungsional di HCG Manavata Cancer Centre.
Dr. Borde telah menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid di HCG Manavata Cancer Centre.
Dr. Sridhar P.S. berspesialisasi dalam radioterapi untuk kanker ginjal di HCG Manavata Cancer Centre, dengan pengalaman lebih dari 20 tahun.
Prof. Tolga Akman berspesialisasi dalam perawatan kanker ginjal di Rumah Sakit Medicana Bahcelievler, termasuk nefrektomi radikal dan parsial.